Renapta Overview
- Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Renapta General Information
Description
Developer of a medical system designed to be used for the treatment of kidney impairment. The company's product is used for the selective clearance of certain uremic toxins from the blood of end-stage renal disease patients undergoing renal dialysis, enabling patients to access kidney impairment treatment.
Contact Information
Website
www.renapta.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Primary Office
- Van Siburgstraat 34
- 3863 HW Nijkerk
- Netherlands
Renapta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-May-2021 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jun-2017 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jan-2010 | Completed | Startup |
Renapta Patents
Renapta Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2897372-A1 | Artificial kidney | Active | 14-Jun-2007 | 0000000000 | |
| CA-2690785-A1 | Artificial kidney | Active | 14-Jun-2007 | 0000000000 | |
| CA-2690785-C | Artificial kidney | Active | 14-Jun-2007 | 0000000000 | |
| CA-2897372-C | Artificial kidney | Active | 14-Jun-2007 | 0000000000 | |
| EP-2402047-A1 | Device for detoxification and use of such a device | Active | 14-Jun-2007 | A61M1/3472 | 0 |
Renapta Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Francis Houwen | Co-Founder | ||
| Jacobus Musters | Co-Founder |
Renapta Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Dutch Ministry of Economic affairs | Government | 000 0000 | 000000 0 |